Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): Naturally selected mutations in IN augment DNA synthesis

Journal of Virology

Volumn 77, Issue 20, 2003, Pages 11050-11059

  Padow, Marcus ^a   Lai, Lilin ^b   Deivanayagam, Champion ^c   DeLucas, Lawrence J ^c   Weiss, Robert B ^d   Dunn, Diane M ^d   Wu, Xiaoyun ^b   Kappes, John C ^a,b,c,e  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CHIMERA; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; VIRUS CULTURE; VIRUS MUTATION; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE; CHIMERA; DNA, VIRAL; GENETIC COMPLEMENTATION TEST; HIV INTEGRASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MUTATION; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0141870046     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.20.11050-11059.2003     Document Type: Article

References (41)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Ansari-Lari, M. A., L. A. Donehower, and R. A. Gibbs. 1995. Analysis of human immunodeficiency virus type 1 integrase mutants. Virology 211:332-335.
3. Ansari-Lari, M. A., and R. A. Gibbs. 1996. Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection. J. Virol. 70:3870-3875.
4. Bukovsky, A., and H. Göttlinger. 1996. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J. Virol. 70:6820-6825.
5. Cannon, P. M., E. D. Byles, S. M. Kingsman, and A. J. Kingsman. 1996. Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. J. Virol. 70:651-657.
6. Carson, M. 1997. RIBBONS. Methods Enzymol. 277:493-505.
7. Engelman, A., G. Englund, J. M. Orenstein, M. A. Martin, and R. Craigie. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736.
8. Engelman, A., Y. Liu, H. Chen, M. Farzan, and F. Dyda. 1997. Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. J. Virol. 71:3507-3514.
9. Ewing, B., L. Hillier, M. C. Wendl, and P. Green. 1998. Base-calling of automated sequencer traces with phred. I. Accuracy assessment. Genome Res. 8:175-185.
10. Ghosh, S. K., P. N. Fultz, E. Keddie, M. S. Saag, P. M. Sharp, B. H. Hahn, and G. M. Shaw. 1993. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology 194:858-864.
11. Goff, S. P. 2001. Retroviridae: the retroviruses and their replication, p. 1871-1939. In D. M. Knipe and P. M. Howley (ed.), Virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
12. Hu, S. C., D. L. Court, M. Zweig, and J. G. I. Levin. 1986. Murine leukemia virus pol gene products: Analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli. J. Virol. 60:267-274.
13. Ishikawa, T., N. Okui, N. Kobayashi, R. Sakuma, T. Kitamura, and Y. Kitamura. 1999. Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal of human immunodeficiency virus type 1 integrase. J. Virol. 73:4475-4480.
14. Kappes, J. C., X. Wu, and J. C. Wakefield. 2003. Production of translentiviral vector with predictable safety, p. 449-465. In C. A. Machida (ed.), Viral vectors for gene therapy. Humana Press, Totowa, N.J.
15. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated B-galactosidase gene. J. Virol. 66:2232-2239.
16. Lai, L., X. Wu, and J. C. Kappes. 2001. Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells. J. Virol. 75:11365-11372.
17. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
18. Leavitt, A. D., G. Robles, N. Alesandro, and H. E. Varmus. 1996. human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70:721-728.
19. Liu, H., X. Wu, H. Xiao, and J. C. Kappes. 1999. Targeting human immunodeficiency virus type 2 (HIV-2) integrase protein into HIV-1. J. Virol. 73:8831-8836.
20. Masuda, T., V. Planelles, P. Krogstad, and I. S. Y. Chen. 1995. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69:6687-6696.
21. Nickerson, D. A., V. O. Tobe, and S. L. Taylor. 1997. PolyPhred: automating the detection and genotyping of single nucleotide substitutions with fluorescence-based resequencing. Nucleic Acids Res. 25:2745-2751.
22. Nymark-McMahon, M. H., N. S. Beliakova-Bethell, J.-L. Darlix, S. F. J. Le Grice, and S. B. Sandmeyer. 2002. Ty3 integrase is required for initiation of reverse transcription. J. Virol. 76:2804-2816
23. Nymark-McMahon, M. H., and B. Sandmeyer. 1999. Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle. J. Virol. 73:453-465.
24. Oz, I., O. Avidan, and A. Hizi. 2002. Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases. Biochem. J. 361:557-566.
25. Platt, E., J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentration on infection by macrophage tropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
26. Quillent, C., A. M. Borman, S. Paulous, C. Dauguet, and F. Clavel. 1996. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology 219:29-36.
27. Roth, M. J. 1991. Mutational analysis of the carboxy terminus of the Moloney murine leukemia virus integration protein. J. Virol. 65:2141-2145.
28. Roth, M. J., P. Schwartzberg, N. Tanese, and S. P. Goff. 1990. Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting. J. Virol. 64:4709-4717.
29. Schwartzberg, P., J. Colicelli, and S. P. Goff. 1984. Construction and analysis of deletion mutations in the pol gene of Moloney leukemia virus: a new viral function required for productive infection. Cell 37:1043-1052.
30. Shehu-Xhilaga, M., M. Hill, J. A. Marshall, J. Kappes, S. M. Crowe, and J. Mak. 2002. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of Pol protein. J. Virol. 76:4331-4340.
31. Shin, C.-G., B. Taddeo, W. A. Haseltine, and C. M. Farnet. 1994. Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J. Virol. 68:1633-1642.
32. Tasara, T., G. Maga, M. O. Hottiger, and U. Hubscher. 2000. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Lett. 507:39-44.
33. Tsurutani, N., M. Kubo, Y. Maeda, T. Ohashi, N. Yamamoto, M. Kannagi, and T. Masuda. 2000. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 74:4795-4806.
34. van Gent, D. C., C. Vink, A. A. M. Oude Groeneger, and R. H. A. Plasterk. 1993. Complementation between HIV integrase proteins mutated in different domains. EMBO J. 12:3261-3267.
35. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
36. Wei, X., J. M. Decker, H. M. Liu, Z. Zhang, R. B. Arani, J. M. Kilby, M. S. Saag, X. Wu, G. M. Shaw, and J. C. Kappes. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
37. Wu, X., H. Liu, H. Xiao, J. A. Conway, E. Hehl, G. V. Kalpana, V. Prasad, and J. C. Kappes. 1999. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J. Virol. 73:2126-2135.
38. Wu, X., H. Liu, H. Xiao, J. A. Conway, E. Hunter, and J. C. Kappes. 1997. Functional RT and IN incorporated into HIV-1 particles independently of the Gag-Pol precursor protein. EMBO J. 16:5113-5122.
39. Wu, X., H. Liu, H. Xiao, J. Kim, P. Seshaiah, G. Natsoulis, J. D. Boeke, B. H. Hahn, and J. C. Kappes. 1995. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J. Virol. 69:3389-3398.
40. Yung, E., M. Sorin, A. Pal, E. Craig, A. Morozov, O. Delattre, J. Kappes, D. Ott, and G. V. Kalpana. 2001. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat. Med. 7:920-926.
41. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.